Last reviewed · How we verify
Fosinopril and Losartan
At a glance
| Generic name | Fosinopril and Losartan |
|---|---|
| Sponsor | Shanghai Municipal Health Bureau |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fosinopril and Losartan CI brief — competitive landscape report
- Fosinopril and Losartan updates RSS · CI watch RSS
- Shanghai Municipal Health Bureau portfolio CI